Thursday, November 12, 2026

Business Technology

3 articles

BlackLine and Oracle Deploy Autonomous AI Agents Across Global Enterprise Finance Systems

BlackLine and Oracle Deploy Autonomous AI Agents Across Global Enterprise Finance Systems

BlackLine launched Agentic Financial Operations while Oracle embedded autonomous AI across its cloud ERP suite, racing to capture the enterprise finance automation market. Nearly 25% of finance leaders globally plan to increase AI spending by over 50%, even as they cut other technology budgets. The shift from rule-based automation to agentic systems marks a technical evolution in how multinational corporations handle financial close and compliance processes.

LM Salvado•
Banks Deploy AI Agents in Production as Cloud Giants Fight for $89 Billion Enterprise Market

Banks Deploy AI Agents in Production as Cloud Giants Fight for $89 Billion Enterprise Market

HSBC, Wells Fargo, and Lloyds Banking Group now run AI systems handling fraud detection and customer service, signaling mainstream enterprise adoption. Snowflake's BUILD London 2026 launch targets this shift with integrated AI infrastructure. Global enterprise AI spending will reach $89 billion by 2027, with financial institutions commanding 18% of total market.

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com